JPY 127.0
(0.79%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.09 Billion JPY | 110.13% |
2022 | 715 Million JPY | -29.54% |
2021 | 843 Million JPY | 4.93% |
2020 | 638 Million JPY | 35.69% |
2019 | -559 Million JPY | -21.92% |
2018 | -285 Million JPY | -37.48% |
2017 | 10 Million JPY | -39.1% |
2016 | -1.26 Billion JPY | 25.66% |
2015 | -2.36 Billion JPY | -2.19% |
2014 | -1.85 Billion JPY | -17.96% |
2013 | -1.41 Billion JPY | -59.57% |
2012 | -884.13 Million JPY | -327.13% |
2011 | 389.26 Million JPY | 197.11% |
2010 | -403.84 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -766.04 Million JPY | -175.18% |
2023 Q3 | -403.65 Million JPY | -774.25% |
2023 FY | - JPY | 110.13% |
2023 Q1 | 129.38 Million JPY | 138.58% |
2023 Q2 | -46.17 Million JPY | -135.68% |
2023 Q4 | 509.59 Million JPY | 226.25% |
2022 FY | - JPY | -29.54% |
2022 Q4 | -335.33 Million JPY | 79.83% |
2022 Q2 | 164.43 Million JPY | 132.83% |
2022 Q1 | -500.87 Million JPY | -334.5% |
2022 Q3 | -1.66 Billion JPY | -1111.28% |
2021 Q2 | -425.86 Million JPY | 44.99% |
2021 FY | - JPY | 4.93% |
2021 Q4 | 213.59 Million JPY | 126.18% |
2021 Q3 | -815.89 Million JPY | -91.59% |
2021 Q1 | -774.12 Million JPY | -80.51% |
2020 FY | - JPY | 35.69% |
2020 Q1 | -374.31 Million JPY | 59.11% |
2020 Q2 | -635.44 Million JPY | -69.76% |
2020 Q3 | -457.06 Million JPY | 28.07% |
2020 Q4 | -428.84 Million JPY | 6.17% |
2019 Q3 | -631.45 Million JPY | -3.68% |
2019 Q4 | -915.46 Million JPY | -44.98% |
2019 FY | - JPY | -21.92% |
2019 Q1 | -791.53 Million JPY | -25.5% |
2019 Q2 | -609.06 Million JPY | 23.05% |
2018 Q3 | -629.92 Million JPY | -13.76% |
2018 FY | - JPY | -37.48% |
2018 Q1 | -603.15 Million JPY | -8.47% |
2018 Q4 | -630.71 Million JPY | -0.13% |
2018 Q2 | -553.73 Million JPY | 8.19% |
2017 Q2 | -389.67 Million JPY | -18.12% |
2017 Q1 | -329.88 Million JPY | -314.34% |
2017 FY | - JPY | -39.1% |
2017 Q4 | -556.04 Million JPY | -15.17% |
2017 Q3 | -482.79 Million JPY | -23.9% |
2016 FY | - JPY | 25.66% |
2016 Q4 | -79.61 Million JPY | 73.7% |
2016 Q3 | -302.75 Million JPY | 15.98% |
2016 Q2 | -360.34 Million JPY | 30.89% |
2016 Q1 | -521.4 Million JPY | 1.9% |
2015 FY | - JPY | -2.19% |
2015 Q1 | -475.49 Million JPY | -28.19% |
2015 Q3 | -424.11 Million JPY | 15.19% |
2015 Q2 | -500.05 Million JPY | -5.17% |
2015 Q4 | -531.52 Million JPY | -25.33% |
2014 Q3 | -437.48 Million JPY | 14.39% |
2014 FY | - JPY | -17.96% |
2014 Q1 | -467.35 Million JPY | -0.95% |
2014 Q2 | -511.03 Million JPY | -9.35% |
2014 Q4 | -370.91 Million JPY | 15.22% |
2013 Q3 | -354.22 Million JPY | 1.09% |
2013 FY | - JPY | -59.57% |
2013 Q1 | -337.05 Million JPY | -21.17% |
2013 Q2 | -358.11 Million JPY | -6.25% |
2013 Q4 | -462.95 Million JPY | -30.69% |
2012 Q4 | -278.15 Million JPY | -17.93% |
2012 Q2 | -230.08 Million JPY | -1.92% |
2012 Q1 | -225.75 Million JPY | -155.32% |
2012 FY | - JPY | -327.13% |
2012 Q3 | -235.86 Million JPY | -2.51% |
2011 Q2 | -151.34 Million JPY | -171.99% |
2011 Q4 | 408.08 Million JPY | 359.87% |
2011 Q1 | 210.22 Million JPY | 0.0% |
2011 FY | - JPY | 197.11% |
2011 Q3 | -157.03 Million JPY | -3.76% |
2010 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
DVx Inc. | 807.98 Million JPY | -158.916% |
Seikagaku Corporation | 2.09 Billion JPY | 0.191% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 63.33% |
Create Medic Co., Ltd. | 1.39 Billion JPY | -50.353% |
PHC Holdings Corporation | 39.08 Billion JPY | 94.648% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | -7.105% |
Rion Co., Ltd. | 4.37 Billion JPY | 52.201% |
Nihon Kohden Corporation | 23.44 Billion JPY | 91.077% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 94.226% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 83.115% |
Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | 36.089% |
CYBERDYNE Inc. | -2 Million JPY | 104700.0% |